Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Atripla

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Atripla was produced by Gilead Sciences.

Gilead sales rise by 13%, buoyed by anti-COVID-19 drug Veklury

Gilead sales rise by 13%, buoyed by anti-COVID-19 drug Veklury

disoproxil) and Atripla (efavirenz/emtricitabine/tenofovir) in the United States.

Gilead’s Q1 revenues lifted by COVID-19 med Veklury as HIV drugs take a hit

Gilead’s Q1 revenues lifted by COVID-19 med Veklury as HIV drugs take a hit Atripla in the US as well as COVID-19 related impacts.

Gilead’s COVID-19 drug Veklury brought in almost $2bn in Q4

Gilead’s COVID-19 drug Veklury brought in almost $2bn in Q4 Gilead has attributed the Q4 decrease to lower sales of its Truvada (emtricitabine/tenofovir)-based products, given that the company lost exclusivity of Truvada and Atripla in the US in October

MSD claims EU approval for two HIV products

MSD claims EU approval for two HIV products Merck has suggested Delstrigo is slightly more effective than Gilead’s widely-prescribed Atripla (efavirenz/emtricitabine/tenofovir disoproxil fumarate), which made $1.3bn in sales last year.

Gilead gets EU nod for TAF-based triple therapy for HIV

Gilead gets EU nod for TAF-based triple therapy for HIV Atripla in 20016. ... Since then, Atripla has grown into a $3bn-plus product. "People living with HIV today are increasingly likely to be receiving treatment for other conditions - such as heart and liver disease -

1 2 3 4 5 6 7 [ Next 5 results ]

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....